{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T17:47:56Z","timestamp":1759600076660},"reference-count":22,"publisher":"The Endocrine Society","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1999,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The syndrome of resistance to thyroid hormone is associated with diverse mutations in the ligand-binding domain of the thyroid hormone \u03b2 receptor, localizing to three clusters around the hormone binding cavity. Here, we report three novel resistance to thyroid hormone mutations (S314C, S314F, and S314Y), due to different nucleotide substitutions in the same codon, occurring in six separate families. Functional characterization of these mutant receptors showed marked differences in their properties. S314F and S314Y receptor mutants exhibited significant transcriptional impairment in keeping with negligible ligand binding and were potent dominant negative inhibitors of wild-type receptor action. In contrast, the S314C mutant bound ligand with reduced affinity, such that its functional impairment and dominant negative activity manifest at low concentrations of thyroid hormone, but are more reversible at higher T3 concentrations. The degree of functional impairment of mutant receptors in vitro may correlate with the magnitude of thyroid dysfunction in vivo. Modelling these mutations using the crystal structure of thyroid hormone receptor \u03b2 shows why ligand binding is perturbed and why the phenylalanine\/tyrosine mutations are more deleterious than cysteine.<\/jats:p>","DOI":"10.1210\/endo.140.12.7203","type":"journal-article","created":{"date-parts":[[2014,1,8]],"date-time":"2014-01-08T16:10:10Z","timestamp":1389197410000},"page":"5901-5906","source":"Crossref","is-referenced-by-count":8,"title":["Three Novel Mutations at Serine 314 in the Thyroid Hormone \u03b2 Receptor Differentially Impair Ligand Binding in the Syndrome of Resistance to Thyroid Hormone1"],"prefix":"10.1210","volume":"140","author":[{"given":"M.","family":"Gurnell","sequence":"first","affiliation":[{"name":"Department of Medicine, University of Cambridge, Addenbrooke\u2019s Hospital (M.G., O.R., M.A., R.J.D.C.-B., V.K.K.C.), Cambridge, United Kingdom CB2 2QQ"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Rajanayagam","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Cambridge, Addenbrooke\u2019s Hospital (M.G., O.R., M.A., R.J.D.C.-B., V.K.K.C.), Cambridge, United Kingdom CB2 2QQ"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Agostini","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Cambridge, Addenbrooke\u2019s Hospital (M.G., O.R., M.A., R.J.D.C.-B., V.K.K.C.), Cambridge, United Kingdom CB2 2QQ"},{"name":"The Dipartimento di Endocrinologia e Metabolismo, Universita\u0300 di Pisa (M.A., E.M., A.P.), 56124 Pisa, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. J. D.","family":"Clifton-Bligh","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Cambridge, Addenbrooke\u2019s Hospital (M.G., O.R., M.A., R.J.D.C.-B., V.K.K.C.), Cambridge, United Kingdom CB2 2QQ"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Wang","sequence":"additional","affiliation":[{"name":"The Department of Clinical Biochemistry, Leicester Royal Infirmary (T.W.), Leicester, United Kingdom LE1 5WW"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. M. J.","family":"Zelissen","sequence":"additional","affiliation":[{"name":"The Department of Endocrinology, University Hospital (P.M.J.Z.), Utrecht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"van der Horst","sequence":"additional","affiliation":[{"name":"The Department of Clinical Chemistry, Eemland Hospital (F.v.d.H.), 3800 BM Amersfoort, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. van de","family":"Wiel","sequence":"additional","affiliation":[{"name":"Department of Endocrinology (Ar.d.W), Eemland Hospital, 3800 BM Amersfoort, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Macchia","sequence":"additional","affiliation":[{"name":"The Dipartimento di Endocrinologia e Metabolismo, Universita\u0300 di Pisa (M.A., E.M., A.P.), 56124 Pisa, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Pinchera","sequence":"additional","affiliation":[{"name":"The Dipartimento di Endocrinologia e Metabolismo, Universita\u0300 di Pisa (M.A., E.M., A.P.), 56124 Pisa, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. W. R.","family":"Schwabe","sequence":"additional","affiliation":[{"name":"The Medical Research Council Laboratory of Molecular Biology (J.W.R.S.), Cambridge, United Kingdom CB2 2QH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V. K. K.","family":"Chatterjee","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Cambridge, Addenbrooke\u2019s Hospital (M.G., O.R., M.A., R.J.D.C.-B., V.K.K.C.), Cambridge, United Kingdom CB2 2QQ"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","reference":[{"key":"2020071620304820100_R1","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1210\/mend-2-12-1217","article-title":"Tight linkage between the syndrome of generalized thyroid hormone resistance and the human c-erbA \u03b2 gene.","volume":"2","author":"Usala","year":"1988","journal-title":"Mol Endocrinol"},{"key":"2020071620304820100_R2","first-page":"348","article-title":"The syndromes of resistance to thyroid hormone.","volume":"14","author":"Refetoff","year":"1993","journal-title":"Endocr Rev"},{"key":"2020071620304820100_R3","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1089\/thy.1994.4.225","article-title":"The variable clinical phenotype in thyroid hormone resistance syndrome.","volume":"4","author":"Beck-Peccoz","year":"1994","journal-title":"Thyroid"},{"key":"2020071620304820100_R4","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1210\/mend-4-12-1988","article-title":"Dominant negative transcriptional regulation by a mutant thyroid hormone receptor \u03b2 in a family with generalised resistance to thyroid hormone.","volume":"4","author":"Sakurai","year":"1990","journal-title":"Mol Endocrinol"},{"key":"2020071620304820100_R5","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1172\/JCI115225","article-title":"Thyroid hormone resistance syndrome: inhibition of normal receptor function by mutant thyroid hormone receptors.","volume":"87","author":"Chatterjee","year":"1991","journal-title":"J Clin Invest"},{"key":"2020071620304820100_R6","first-page":"1262","article-title":"Spectrum of transcriptional, dimerization and dominant negative properties of twenty different mutant thyroid hormone \u03b2-receptors in thyroid hormone resistance syndrome.","volume":"8","author":"Collingwood","year":"1994","journal-title":"Mol Endocrinol"},{"key":"2020071620304820100_R7","doi-asserted-by":"crossref","first-page":"13014","DOI":"10.1016\/S0021-9258(18)42375-7","article-title":"Thyroid hormone receptor mutants that cause resistance to thyroid hormone: evidence for receptor competition for DNA sequences in target genes.","volume":"267","author":"Nagaya","year":"1992","journal-title":"J Biol Chem"},{"key":"2020071620304820100_R8","doi-asserted-by":"crossref","first-page":"15766","DOI":"10.1016\/S0021-9258(18)82321-3","article-title":"Thyroid hormone receptor dimerization is required for dominant negative inhibition by mutations that cause thyroid hormone resistance.","volume":"268","author":"Nagaya","year":"1993","journal-title":"J Biol Chem"},{"key":"2020071620304820100_R9","first-page":"1262","article-title":"A novel TR\u03b2 mutation (R383H) in resistance to thyroid hormone predominantly impairs corepressor release and negative transcriptional regulation.","volume":"8","author":"Clifton-Bligh","year":"1998","journal-title":"Mol Endocrinol"},{"key":"2020071620304820100_R10","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1172\/JCI117362","article-title":"Genetic analysis of 29 kindreds with generalized and pituitary resistance to thyroid hormone.","volume":"94","author":"Adams","year":"1994","journal-title":"J Clin Invest"},{"key":"2020071620304820100_R11","doi-asserted-by":"crossref","first-page":"4760","DOI":"10.1093\/emboj\/17.16.4760","article-title":"A role for helix 3 of the TR\u03b2 ligand binding domain in coactivator recruitment identified by characterization of a third cluster of mutations in resistance to thyroid hormone.","volume":"17","author":"Collingwood","year":"1998","journal-title":"EMBO J"},{"key":"2020071620304820100_R12","doi-asserted-by":"crossref","first-page":"3565","DOI":"10.1016\/S0021-9258(19)50559-2","article-title":"Triiodothyronine (T3) decreases binding to DNA by T3-receptor homodimers but not receptor auxillary protein heterodimers.","volume":"267","author":"Yen","year":"1992","journal-title":"J Biol Chem"},{"key":"2020071620304820100_R13","doi-asserted-by":"crossref","first-page":"3246","DOI":"10.1210\/jcem.80.11.7593433","article-title":"Do clinical manifestations of resistance to thyroid hormone correlate with the functional alteration of the corresponding mutant thyroid hormone\u03b2 receptors?","volume":"80","author":"Hayashi","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071620304820100_R14","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1172\/JCI116474","article-title":"Identical mutations in unrelated families with generalized resistance to thyroid hormone occur in cytosine-guanine-rich areas of the thyroid hormone receptor beta gene.","volume":"91","author":"Weiss","year":"1993","journal-title":"J Clin Invest"},{"key":"2020071620304820100_R15","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1172\/JCI116793","article-title":"Interaction of human\u03b2 1 thyroid hormone receptor and its mutants with DNA and retinoid X receptor \u03b2. T3 response element-dependent dominant negative potency.","volume":"92","author":"Meier","year":"1993","journal-title":"J Clin Invest"},{"key":"2020071620304820100_R16","first-page":"248","article-title":"Variable transcriptional activity and ligand binding of mutant \u03b21 3,5,3\u2032-triiodothyronine receptors from four families with generalised resistance to thyroid hormone.","volume":"6","author":"Meier","year":"1992","journal-title":"Mol Endocrinol"},{"key":"2020071620304820100_R17","first-page":"563","article-title":"Thyroid hormone receptor homodimers can function as ligand-sensitive repressors.","volume":"9","author":"Piedrafita","year":"1995","journal-title":"Mol Endocrinol"},{"key":"2020071620304820100_R18","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1210\/endo.136.7.7789309","article-title":"Studies on the repression of basal transcription (silencing) by artificial and natural human thyroid hormone receptor-\u03b2 mutants.","volume":"136","author":"Yen","year":"1995","journal-title":"Endocrinology"},{"key":"2020071620304820100_R19","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1089\/thy.1995.5.343","article-title":"Dominant negative and DNA-binding properties of mutant thyroid hormone receptors that are defective in homodimerization but not heterodimerization.","volume":"5","author":"Kitajima","year":"1995","journal-title":"Thyroid"},{"key":"2020071620304820100_R20","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1126\/science.280.5370.1747","article-title":"Hormone-dependent coactivator binding to a hydrophobic cleft on nuclear receptors.","volume":"280","author":"Feng","year":"1998","journal-title":"Science"},{"key":"2020071620304820100_R21","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.1210\/jcem.80.12.8530608","article-title":"Three novel mutations of thyroid hormone receptor \u03b2 gene in unrelated patients with resistance to thyroid hormone: two mutations of the same codon (H435L and H435Q) produce separate subtypes of resistance.","volume":"80","author":"Tsukaguchi","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071620304820100_R22","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0303-7207(90)90245-4","article-title":"Structural analysis of human thyroid hormone receptor \u03b2 gene.","volume":"71","author":"Sakurai","year":"1990","journal-title":"Mol Cell Endocrinol"}],"container-title":["Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/140\/12\/5901\/10382942\/endo5901.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/140\/12\/5901\/10382942\/endo5901.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T23:10:50Z","timestamp":1647904250000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/endo\/article\/140\/12\/5901\/2990968"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,12,1]]},"references-count":22,"journal-issue":{"issue":"12","published-print":{"date-parts":[[1999,12,1]]}},"URL":"https:\/\/doi.org\/10.1210\/endo.140.12.7203","relation":{},"ISSN":["0013-7227","1945-7170"],"issn-type":[{"value":"0013-7227","type":"print"},{"value":"1945-7170","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,12,1]]}}}